Tamanho ao nascer e pressão arterial em adultos jovens: achados de uma coorte de nascimentos brasileira
Tamaño al nacer y presión arterial en adultos jóvenes: resultados de una cohorte de nacimientos brasileña
Viviane Cunha CardosoI; Javier MeritanoII; Antônio Augusto Moura da SilvaIII; Heloísa BettiolI; Marco Antonio BarbieriI; Carlos GrandiII
IDepartamento de Puericultura e Pediatria. Faculdade de Medicina de Ribeirão Preto. Universidade de São Paulo. Ribeirão Preto, SP, Brasil
IIDepartamento de Pediatria do Hospital Materno-Infantil Ramón Sardá. Faculdade de Medicina. Universidade de Buenos Aires. Ciudad Autónoma de Buenos Aires, BUE, Argentina
IIIDepartamento de Saúde Pública. Universidade Federal do Maranhão. São Luís, MA, Brasil
OBJECTIVE: To describe the prevalence of borderline blood pressure (BBP) and hypertension (HT) among young adults and to assess the association between size at birth and BBP/HT.
METHODS: Data were collected from the first Ribeirão Preto Birth Cohort Study conducted in the city of Ribeirão Preto, southeastern Brazil, that started in 1978-1979. Of the 6,827 singletons born in hospitals, 2,060 were assessed at 23-25 years of age. Blood samples were collected, an anthropometric assessment was performed, and information was obtained regarding occupation, schooling, life habits and chronic diseases. Blood pressure (BP) was classified as: 1) BBP: systolic BP (SBP) ≥ 130 mm Hg and < 140 mm Hg and/or diastolic BP (DBP) ≥ 85 mm Hg and < 90 mm Hg; and 2) HT: SBP ≥ 140 mm Hg and/or DBP ≥ 90 mm Hg. A polytomic logistic regression model was used.
RESULTS: BBP prevalence was 13.5% (males: 23.2%) and HT prevalence 9.5% (males: 17.7%). BBP was independently associated with male gender (relative risk [RR] 8.84; 95%CI 6.09;12.82); birth length ≥ 50 cm (RR 1.97; 1.04;3.73); body mass index (BMI) ≥ 30 kg/m2 (RR 3.23; 2.02;5.15); and high waist circumference (RR 1.61; 1.13;2.29), while HT was associated with male gender (RR 15.18; 8.92;25.81); BMI ≥ 30 kg/m2 (RR 3.68; 2.23;6.06); high waist circumference (RR 2.68; 1.77;4.05); and elevated blood glucose (RR 2.55; 1.27; 5.10), but not with birth length.
CONCLUSIONS: The prevalence of BBP and HT among young adults of this cohort was higher in males than females. Greater birth length was associated with BBP, but not with HT, whereas birth weight was not associated with either BBP or HT. Adult risk factors explained most of the increase in the levels of BBP and HT.
Descriptors: Borderline blood pressure, hypertension, birth weight, birth length, young adults, cohort studies, obesity, abdominal obesity, high blood glucose.
OBJETIVO: Descrever a prevalência de pressão arterial limítrofe (PAL) e hipertensão (HT) entre adultos jovens e avaliar a associação entre tamanho ao nascer e PAL/HT.
MÉTODOS: Dados foram coletados do primeiro estudo brasileiro de coorte de nascimentos em Ribeirão Preto (sudeste do Brasil), iniciado em 1978/79. De 6.827 recém-nascidos de parto único hospitalar, 2.060 foram avaliados aos 23/25 anos. Foram realizadas coleta de sangue, avaliação antropométrica e obtidas informações sobre ocupação, escolaridade, hábitos de vida e doenças crônicas. Pressão arterial (PA) foi classificada em: 1) PAL: PA sistólica (PAS) ≥ 130 e < 140 mm Hg e/ou PA diastólica (PAD) ≥ 85 e < 90 mmHg; 2) HT: PAS ≥ 140 e/ou PAD ≥ 90 mm Hg. Foi aplicado modelo de regressão logística politômica.
RESULTADOS: A prevalência de PAL foi de 13,5% (homens 23,2%) e a de HT, 9,5% (homens 17,7%). PAL foi independentemente associada com sexo masculino (RR 8,84; IC95%: 6,09;12,82), comprimento ao nascer ≥ 50 cm (RR 1,97; 1,04; 3,73), índice de massa corporal (IMC) ≥ 30 kg/m2 (RR 3,23; 2,02; 5,15) e circunferência de cintura alterada (RR 1,61; 1,13;2,29), enquanto HT associou-se com sexo masculino (RR 15,18; 8,92;25,81), IMC ≥ 30 kg/m2 (RR 3,68; 2,23;6,06), circunferência de cintura alterada (RR 2,68; 1,77;4,05) e glicemia elevada (RR 2,55; 1,27;5,10), mas não com comprimento ao nascer.
CONCLUSÕES: As prevalências de PAL e HT entre os adultos jovens dessa coorte foram maiores em homens que em mulheres. Maior comprimento ao nascer foi associado com PAL, mas não com HT, enquanto peso ao nascer não foi associado com PAL ou HT. Fatores de risco do adulto explicaram a maioria dos aumentos de PAL ou HT.
Descritores: Pressão arterial limítrofe, hipertensão, peso ao nascer, comprimento ao nascer, adultos jovens, estudos de coortes, obesidade, obesidade abdominal, glicemia elevada.
OBJETIVO: Describir la prevalencia de presión arterial limítrofe (PAL) e hipertensión (HT) entre adultos jóvenes y evaluar la asociación entre tamaño al nacer y PAL/HT.
MÉTODOS: : Los datos fueron colectados en el primer estudio de cohorte de nacimientos brasileño en Ribeirao Preto (sureste de Brasil), iniciado en 1978/79. De 6.827 recién nacidos de parto único hospitalario, 2.060 fueron evaluados a los 23/25 años. Se realizaron colecta de sangre, evaluación antropométrica y obtenidas informaciones sobre ocupación, escolaridad, hábitos de vida y enfermedades crónicas. Presión arterial (PA) fue clasificada en: 1) PAL: PA sistólica (PAS) ≥ 130 y < 140 mm Hg y/o PA diastólica (PAD) ≥ 85 y < 90 mm Hg; 2) HT: PAS ≥ 140 y/o PAD ≥ 90 mm Hg. Se aplicó modelo de regresión logística politómica.
RESULTADOS: La prevalencia de PAL fue de 13,5% (hombres 23,2%) y la de HT, 9,5% (hombres 17,7%). PAL fue independientemente asociada con sexo masculino (Riesgo Relativo - RR) 8,84; 95%IC: 6,09;12,82), estatura al nacer ≥ 50 cm (RR 1,97; 1,04; 3,73), índice de masa corporal (IMC) ≥ 30 kg/m2 (RR 3,23; 2,02; 5,15) y circunferencia de cintura alterada (RR 1,61; 1,13;2,29), mientras el HT se asoció con sexo masculino (RR 15,18; 8,92;25,81), IMC ≥ 30 kg/m2 (RR 3,68; 2,23;6,06), circunferencia de cintura alterada (RR 2,68; 1,77;4,05) y glicemia elevada (RR 2,55; 1,27;5,10), pero no con estatura al nacer.
CONCLUSIONES: Las prevalencias de PAL y HT entre los adultos jóvenes de la cohorte fueron mayores en hombres que en mujeres. Mayor estatura al nacer fue asociado con PAL, pero no con HT, mientras que el peso al nacer no estuvo asociado con PAL o HT. Factores de riesgo de adulto explicaron la mayoría de los aumentos de PAL o HT.
Descriptores: Presión arterial limítrofe, hipertensión, peso al nacer, estatura al nacer, adultos jóvenes, estudios de cohortes, obesidad, obesidad abdominal, glicemia elevada.
Essential hypertension is an important risk factor for morbidity and mortality from coronary heart disease, stroke, and renal disease.26 Although clinical manifestations of hypertension (HT) do not generally emerge until middle age, the pathophysiologic precursors of adult HT are thought to originate very early in life even during fetal development.
Fetal growth disorders are associated with chronic non-communicable diseases in adulthood, among them HT, according to the fetal origins of adult disease hypothesis.6 However, it is not clear whether early life factors such as weight and length at birth are also associated with borderline blood pressure (BBP).
Prospective studies show that HT is preceded by a prehypertension stage characterized by abnormalities considered as potential metabolic precursors of HT.14,24
The course of concurrent development of adverse blood pressure (BP) levels and other risk factors for the metabolic syndrome during childhood, adolescence, and young adulthood still needs elucidation. BBP, a new risk category for Latin American and European countries, includes a population at high risk of developing HT and in which lifestyle modifications are needed. This might be useful not only in assessing future risk of hypertension but also in prevention and intervention algorithms.11
This study aimed to describe the prevalence of BBP and HT among young adults and to assess the association between size at birth and BBP/HT.
Study carried out with data from the first Ribeirão Preto Birth Cohort Study conducted in the city of Ribeirão Preto, southeastern Brazil, that started in 1978-1979. Data were obtained at birth and at young adult age (23 to 25 years). There were recruited 9,067 liveborn infants delivered at the city's eight maternity hospitals from June 1st, 1978 to May 31, 1979 (98% of all live births). Infants whose families did not reside in the city (2,094) and twins (146) were excluded from the study, remaining 6,827 live births.9 Information about mother's age, schooling and smoking was obtained through interviews with the mothers after delivery and review of medical records at the maternity hospitals. Birth weight and length were measured within 30 minutes of birth by trained personnel with appropriate devices that were donated by the research team to all hospitals. The infants were weighed naked on scales that were calibrated on a weekly basis with 10-g precision (Filizola, São Paulo, Brazil). Two trained staff members measured length at birth with the infants lying in the supine position on a neonatometer with a fixed vertical headpiece and a smooth sliding vertical footpiece. Measurements were taken to the nearest 0.5 cm.
From the original cohort, 30% of subjects were selected to participate in the adult follow-up (between 2002 and 2004). This sample size was enough to test the study hypothesis. Of 6,827 singleton liveborns, 343 subjects were found to be deceased and 819 could not be traced, leaving 5,665 singletons. Subjects were classified according to the income of the head of the family (geoeconomic classification) to ensure a representative sample of socioeconomic groups. One in every three subjects from the same geographic area was invited to undergo medical examination. The first of every three names was selected from a list sorted by birth date in each geographic area, and if unavailable the next name down was selected. Losses to follow-up (n = 705) occurred because of refusal to participate, imprisonment, death after 20 years of age, or failure to show up for the interview. Losses were replaced using the same sampling method, resulting in 2,063 young adults (Figure).5 Data were obtained by structured questionnaires, physical examination, and blood collection. Anthropometric measurements (weight, height, and waist circumference) were taken according to standardized techniques with subjects barefoot and wearing light clothing. The instruments used were a precision scale periodically calibrated, anthropometers for standing and sitting measurements, a non-extensible metric tape and a caliper. Blood pressure was measured three times using a digital sphygmomanometer with a cuff of the same size which was adjusted to the arm circumference. The measurements were taken by the same examiner at 15-min intervals, with the subject resting in the sitting position with the left arm at the height of his/her heart. The mean of the last two measurements was then calculated.
Three of 2,063 subjects were excluded because of technical difficulties in recording BP (extreme obesity), totaling 2,060 young adults. A sample size of 1,291 was needed to test the study hypothesis assuming the event had a 10% prevalence with a 5% probability of type I error and 1% precision. Details regarding the methodology are available elsewhere.5,9
Blood pressure was the primary outcome measure and was classified into three groups: 1) normal blood pressure (NT): systolic BP (SBP) < 130 mm Hg and/or diastolic BP (DBP) < 85 mm Hg; 2) borderline blood pressure (BBP): SBP 130 mm Hg to 139 mm Hg and/or DBP 85 mm Hg to 89 mm Hg; 3) hypertension (HT): SBP ≥ 140 mm Hg and/or DBP ≥ 90 mm Hg according to Argentinean, Brazilian, and European guidelines.12,23,25
Sociodemographic characteristics were evaluated at birth: mother's age (years), maternal schooling (years), occupation of the head of the family according to the International Standard Classification of Occupation21 and maternal smoking (no smoking; 1-10; > 10 cigarettes). Gender, gestational age, birth weight (BW), length, ponderal index (PI, kg/m3), and adverse perinatal outcomes (low birth weight [LBW, < 2,500 g], small for gestational age [SGA, BW lower than the 10th percentile27], preterm birth [< 37 completed weeks]) were presented.
Adulthood sociodemographic characteristics evaluated were: occupation of the head of the family; smoking habit (no smoking; 1-10; > 10 cigarettes); physical activity (active, sufficiently active, and inactive according to the International Physical Activity Questionnaire scoring protocol);ª alcohol consumption (g/day; high > 31 g/day; low < 31 g/day).4
The recommendation of the World Health Organization (WHO) of a daily intake of < 5.0 g of salt (2,000 mg of sodium) was adopted to define the cut-off of high sodium intake in mg/day.28
Obesity in adulthood was defined as BMI ≥ 30 kg/m2. Abdominal obesity was based on the waist circumference cut-offs proposed for the metabolic syndrome classification by the International Diabetes Federation.2 Fasting blood glucose was determined by the GOD/PAP human diagnostic colorimetric enzymatic method (Chronolab AG, Zug, Switzerland) and was considered high when ≥ 100 mg/dL.2 Total cholesterol, HDL cholesterol, and triglycerides were determined by an enzymatic colorimetric method using the Dade Behring XPand device (Dade Behring, Liederbach, Germany) and reagents of Dade Behring Dimension clinical chemistry. Insulin resistance was estimated by a so-called surrogate marker,18 the triglyceride-to-high density lipoprotein (TG/HDL) ratio, which has been proposed as one of the most accurate surrogate markers; optimal cut-off was 2.90 or less.
All variables are presented as proportions (n, %) and the three levels of blood pressure were compared by the chi-square test.
A univariate risk analysis between BBP/HT and covariates was performed. The variables with a p < 0.05 were included in a polytomic logistic regression analysis to evaluate the risk of both BBP and HT; SBP < 130 mm Hg and/or DBP < 85 mm Hg were the reference values. To be consistent with the literature, we opted to keep birth weight as a covariate in the regression models.
Three models were constructed: the first one (1) was adjusted for sociodemographic and clinical conditions at birth; the second one (2) include sociodemographic and clinical conditions and biochemical markers during young adulthood; and the third one (3) was adjusted for variables included in previous models. Interaction terms were tested for significance. The models were tested for collinearity using the ''vif'' command of the Stata software, version 9.0 (College Station, Texas, USA). Statistically significant difference was set at p < 0.05.
The study was approved by the Research Ethics Committee of Ribeirão Preto University Hospital, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (HCFMRP-USP). Confidentiality was ensured.
The study sample at birth and at 23-25 years of age was comparable with the original population regarding birth variables: birth weight (p = 0.618) and length (p = 0.507), SGA (p = 0.513), and maternal age at delivery (p = 0.065). There were slight differences between those followed up and those who did not participate. There was a predominance of women (p = 0.004), preterms (p = 0.037), belonging to families with more qualified occupations (p < 0.001), mothers with five years or more of schooling (p < 0.001), married mothers (p < 0.001), and who did not smoke at the time of delivery (p < 0.001) (data not shown).
Males accounted for 48.2% (95%CI 46.1;50.4) of the sample. The prevalence of BBP was 13.5% (n = 279, 95%CI 12.1;15.0) and HT 9.5% (n = 196, 95%CI 8.3;10.8). BBP and HT were significantly higher in males than females (23.2% vs. 4.5% for BBP and 17.7% vs. 1.9% for HT, respectively, p< 0.001).
BBP and HT were positively associated with birth length but not with birth weight. Subjects with a birth length of 50 cm or more had significantly greater proportions of BBP and HT. Ponderal index was not associated with blood pressure.
No differences were observed for maternal characteristics at birth, preterm, LBW or BW for gestational age according to blood pressure levels (Table 1).
Occupation of the head of the family and smoking were not significantly associated with BP levels among young adults. A physically active life, high alcohol consumption, and elevated sodium intake per day were significantly higher in BBP/HT. Subjects with BBP and HT tended to have high BMI (≥ 30 kg/m2) and abdominal obesity. Similar findings were found for high fasting blood glucose and triglyceride/HDL cholesterol ratio > 2.90 (Table 2).
Male gender showed the strongest association with BP levels in univariate analyses at birth; there was an eight-fold increase in the effect estimate (crude relative risk [RR] 8.18, 95%CI 5.89;11.34) for BBP and a fourteen-fold increase for HT (RR 14.96, 95%CI 9.31;24.02) in males compared to females (p < 0.001). Birth length > 50 cm showed a significantly increase only for the risk of BBP (RR 1.92, 95%CI 1.20;3.05, p = 0.006). BW had no effect on blood pressure either BBP or HT, whereas a significant association between ponderal index < 2.5 kg/m3 and blood pressure was seen (RR 1.64, 95%CI 1.03;2.61 and 1.86, 95%CI 1.05;3.27 for BBP and HT, respectively).
The following conditions showed significantly high RR for both BBP and HT, being higher for the latter in young adults: high alcohol consumption (RR 2.09, 95%CI 1.44;3.04 and 3.83, 95%CI 2.46;5.98 for BBP and HT, respectively); sodium intake > 2,000 mg/day (RR 1.39, 95%CI 1.06;1.82 and 1.65, 95%CI 1.20;2.28 for BBP and HT, respectively); BMI ≥ 30 kg/m2 (RR 3.38, 95%CI 2.40;4.74 and 5.62, 95%CI 3.94;8.01 for BBP and HT, respectively); abdominal obesity (RR 2.49, 95%CI 1.92;3.23 and 4.47, 95%CI 3.28;6.09 for BBP and HT); high fasting blood glucose (RR 2.69, 95%CI 1.49;4.85 and 4.49, 95%CI 2.52;7.98 for BBP and HT); and elevated triglyceride/HDL cholesterol ratio (RR 2.77, 95%CI 2.06;3.71 and 4.07, 95%CI 2.95;5.62 for BBP and HT, respectively). Smoking was only associated with HT (RR 1.77, 95%CI 1.07;2.91) (data not shown).
In the model 1 (birth) of the polytomic logistic regression analysis, the magnitude of the association of male gender with BBP/HT and birth length with BBP persisted after adjustment. In the model 2 (adulthood), the risk for BBP increased in males. The positive associations between alcohol consumption, sodium intake ≥ 2,000 mg/day, smoking, and triglyceride/HDL cholesterol ratio were no longer significant, whereas additional adjustment removed part of the effect of BMI ≥ 30 kg/m2 and central obesity on the risk of BBP and HT. Similarly, the positive association between high fasting blood glucose and HT was reduced but remained significantly associated, while for BBP it was reduced and was no longer significant after adjustment.
The model 3 shows the combined effect of birth plus adulthood variables. For both BBP and HT, the associations were mostly consistent with those observed in previous models for male gender, BMI ≥ 30 kg/m2 and central obesity. Birth length ≥ 50 cm remained associated with BBP, while high fasting blood glucose was only associated with HT. BW was not associated with BBP or HT. The replacement of BW and birth length by PI was found to have an inverse association with BBP (adjusted RR [adjRR] 1.91, 95%CI 1.14;3.20) and HT (adjRR 2.29, 95%CI 1.17; 4.4) (Table 3).
There was no evidence of collinearity in the models (Table 3). Interaction terms were tested, but none was significant at the 0.05 level.
One of a few studies conducted in Brazil and Latin American middle-income countries has investigated the suggested association between weight and size at birth and BBP/HT at 23-25 years of age in a population-based sample. Among indicators of size at birth, only birth length was independently associated with BBP at young adulthood. When BBP was replaced by prehypertension (SBP 120 mm Hg to 139 mm Hg or DBP 80 mm Hg to 89 mm Hg according to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [JNC 7])10 in the model 3, birth length showed a significant positive association with BBP but to a lesser extent (RR 1.079, 95%CI 1.002;1.162) while BW was not associated with either prehypertension or HT.
Consistent with the Barker hypothesis, low birth weight is related to higher blood pressure later in life in prospective cohort studies. However, other studies have not been able to support this association.13,20
The prevalence of HT between 18 and 39 years of age was 7.2% in The National Health and Nutrition Examination Survey (NHANES) III,15 a proportion that is close to that seen in our study (9.5%).
The higher prevalence of HT among men compared to women is noteworthy but at a lesser rate compared with similar studies.22,8 This may be attributable to a protective effect of estrogen,19 higher smoking rates among men (most of the female subjects were non-smokers), higher male height (1.76; standard deviation [SD] 6.48 m for men vs. 1.62; SD 6.45 m for women, p < 0.001), elevated sodium intake ≥ 2,000 mg/day (70 vs. 52%, p < 0.001) and abnormal triglyceride/HDL cholesterol ratio (27% vs. 11%, p < 0.001) in males compared to females (data not shown).
There was a lower risk of central obesity (RR 0.78 [95%CI 0.69;0.89], p < 0.001) and biochemical markers among women compared to men (data not shown). Increases in body fat may have different effects in women than men, and that a greater degree of adiposity must be achieved in women to obtain a significant rise in blood pressure and an increase in a lipid risk profile comparable with that of men.
Birth length was positively associated with BBP at the age of 23-25 years. The association between birth length and blood pressure is controversial. Studies from high-income countries, where intrauterine growth restriction is rare, have either failed to report an association or found inverse associations.3,17 On the other hand, studies from low- and middle-income settings have reported positive associations in accordance with the present findings and a previous Brazilian study.20 This is in agreement with a recent systematic review which showed that the association between birth size and later blood pressure varies according to the level of economic development of the country of birth.1
The biological mechanisms by which birth length may influence blood pressure are not yet clear. High blood pressure seen in individuals with higher birth length could be associated to greater height in adulthood.
This was confirmed in a subsequent analysis in which height above the mean of this population (169.0 cm, SD 9.3 cm) was statistically associated with an increase in the risk of either BBP (OR 6.01, 95%CI 4.37;8.27, p < 0.001) or HT (OR 6.84, 95%CI 4.63;10.14, p < 0.001) compared with those at or below 169.0 cm (data not shown).
Further studies are needed to confirm this association and to clarify potential biological mechanisms.
Subjects with BBP and hypertension showed as young adults an increased prevalence of cardiovascular risk factors for the metabolic syndrome, such as measures of generalized and visceral obesity, adverse glucose homeostasis, and dyslipidemia (Table 2).
Near fifty percent of these young adults lead a sedentary life, which could contribute to higher adiposity and impaired cardiovascular health later in life, in accordance with similar studies.13
Our study agrees with Bergvall et al7 findings that the association of size at birth and blood pressure appears not to be confounded by socioeconomic or family effects.
Subjects with hypertension during young adulthood showed high alcohol consumption, sodium intake ≥ 2,000 mg/day, and components of the metabolic syndrome (Tables 2-3). These results are consistent with the tracking concept (persistence) that risk factors remain relatively constant over time. Persistence of high blood pressure over time has been demonstrated in both pediatric and adult populations. This is an important public health issue because of the morbidity and mortality related to HT. Monitoring of BP in these individuals is recommended.
Some of the mechanisms underlying the associations in this study are unclear. Nevertheless, several recognized mechanisms could be postulated such as obesity, hyperinsulinemia/insulin resistance, high sodium intake, and inflammatory markers.11
This is the first study that included BBP, a new category of blood pressure classification in Latin American countries. The sample followed up from birth to young adulthood showed better sociodemographic conditions than the original population.
The results of the present study expand a limited body of evidence supporting the hypothesis that BBP increases the risk of progression to full-blown hypertension in young adults.
To the extent that unmeasured risk factors present at baseline may be positively correlated with BBP, there is a chance that BBP was overestimated. Previous observational studies10,25 have reported that the average BP in the second visit may be lower than in the initial visit due to regression to the mean or the familiarization of the participants to the clinic setting (white coat effect). Consequently, the prevalence of BBP/HT may be overestimated.
Our control variables have other shortcomings mainly because this study started collecting data more than 30 years ago when risk factors and levels of risk factors were less well established. Misreporting of alcohol consumption may have occurred.
The validity of associations between birth weight and health in later life might be due in part to inappropriate statistical adjustment for variables on the causal pathway which creates an artifactual statistical effect, known as the reversal paradox.16
The data obtained for this large community-based birth cohort support the hypothesis that birth length is positively and independently related to blood pressure in early adulthood but do not support an inverse association between birth weight and blood pressure. Adult risk factors explained most of the increase in the levels of BBP and HT.
Moreover, the simultaneous inclusion of current BMI with weight and length at birth in the regression model (indicating an effect of postnatal growth) did not substantially change the effect on the risk of BBP.
Young adults with either BBP or HT showed excess adiposity. These results, when analyzed in the context of the upward secular trends in adiposity and blood pressure in Brazilian youth, underscore the importance of controlling excess adiposity early in life in the general population.
Investigation of causative and synergistic interactions of high blood pressure and other cardiovascular risk factors and of precise physiologic mechanisms associated with early onset of high blood pressure is warranted.
1. Adair L, Dahly D. Developmental determinants of blood pressure in adults. Annu Rev Nutr. 2005;25:407-34. DOI:10.1146/annurev.nutr.25.050304.092538
2. Alberti K, Zimmet P, Shaw J. Metabolic syndrome - a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-80. DOI:10.1111/j.1464-5491.2006.01858.x
3. Andersson SW, Lapidus L, Niklasson A, Hallberg L, Bengtsson C, Hulthén L. Blood pressure and hypertension in middle-aged women in relation to weight and length at birth: a follow-up study. J Hypertens. 2000;18(12):1753-61. DOI:10.1097/00004872-200018120-00008
4. Avesani CM, Santos NS, Cuppari L. Necessidades e recomendações de energia. In: Cuppari L coordenador. Guia de nutrição: nutrição clínica no adulto. Barueri: Manole; 2002. p.27-45.
5. Barbieri MA, Bettiol H, Silva AA, Cardoso VC, Simões VM, Gutierrez MR, et al. Health in early adulthood: the contribution of the 1978/79 Ribeirão Preto birth cohort. Braz J Med Biol Res. 2006;39(8):1041-55. DOI:10.1590/S0100-879X2006000800007
6. Barker DJP, Osmond C, Golding J, Kuh D, Wadsworth MEJ. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989;298(6673):564-7. DOI:10.1136/bmj.298.6673.564
7. Bergvall N, Iliadou A, Tuvemo T, Cnattingius S. Birth characteristics and risk of high systolic blood pressure in early adulthood: socioeconomic factors and familial effects. Epidemiology. 2005;16(5):635-40. DOI:10.1097/01.ede.0000172134.45742.49
8. Brion M, Leary S, Lawlor D, Smith G, Ness A. Modifiable maternal exposures and offspring blood pressure: a review of epidemiological studies of maternal age, diet, and smoking. Pediatr Res. 2008; 63(6):593-8. DOI:10.1203/PDR.0b013e31816fdbd3
9. Cardoso VC, Simões VMF, Barbieri MA, Silva AAM, Bettiol H, Alves MTSSB, et al. Profile of three Brazilian cohort studies in Ribeirão Preto, SP and São Luís, MA. Braz J Med Biol Res. 2007;40(9):1165-76. DOI:10.1590/S0100-879X2006005000148
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72. DOI:10.1001/jama.289.19.2560
11. Chrysohoou C, Pitsavos C, Panagiotakos D, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease: the ATTICA study. Am J Hypertens. 2004;17(7):568-73. DOI:10.1016/j.amjhyper.2004.03.675
12. Consenso Argentino de Hipertensión Arterial. Rev Argent Cardiol. 2007;75(Suppl. 3):1-43.
13. Evensen K, Steinsham S, Tjøonna A, Tjønna A, Stølen T, Høydal M, et al. Effects of preterm birth and fetal growth retardation on cardiovascular risk factors in young adulthood. Early Hum Dev. 2009;85(4):239-45. DOI:10.1016/j.earlhumdev.2008.10.008
14. Haffner SM, Ferrannini E, Hazuda HP, Stern M. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension.1992;20(1):38-45. DOI:10.1161/01.HYP.20.1.38
15. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290(2):199-206. DOI:10.1001/jama.290.2.199
16. Tu YK, West R, Ellison G, Gilthorpe M. Why evidence for the fetal origins of adult disease might be a statistical artifact: the "reversal paradox" for the relation between birth weight and blood pressure in later life. Am J Epidemiol. 2005;161(1):27-32. DOI:10.1093/aje/kwi002
17. Järvelin MR, Sovio U, King V, Lauren L, Xu B, McCarthy MI, et al. Early life factors and blood pressure at age 31 years in the 1966 northern Finland birth cohort. Hypertension. 2004;44(6):838-46. DOI:10.1161/01.HYP.0000148304.33869.ee
18. McLauguin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139(10):802-9.
19. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340(23):1801-11. DOI:10.1056/NEJM199906103402306
20. Menezes A, Hallal P, Horta B, Araújo C, Vieira M, Neutzling M, et al. Size at birth and blood pressure in early adolescence: a prospective birth cohort study. Am J Epidemiol. 2007;165(6):611-61. DOI:10.1093/aje/kwk031
21. Olsen J, Frische G. Social differences in reproductive health. A study on birth weight, stillbirths and congenital malformations in Denmark. Scand J Soc Med. 1993;21(2):90-7.
22. Sakata A, Mogi M, Ito M, Horiuchi M. Listening to the sound of silence between men and women. Hypertension Res. 2010;33(7):668-9. DOI:10.1038/hr.2010.96
23. Sociedade Brasileira de Cardiologia; Sociedade Brasileira de Hipertensão; Sociedade Brasileira de Nefrologia. VI Diretrizes Brasileiras de Hipertensão. Arq Bras Cardiol. 2010;95(1 Supl 1):1-51. DOI:10.1590/S0066-782X2010001700001
24. Sun Z, Zheng L, Detrano R, Zhang X, Xu C, Li J, et al. Risk of progression to hypertension in a rural chinese women population with prehypertension and normal blood pressure. Am J Hypertens. 2010;23(6):627-32. DOI:10.1038/ajh.2010.41
25. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management Of Arterial Hypertension: The Task Force For The Management Of Arterial Hypertension Of The European Society Of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28(12):1462-536.
26. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannell WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345(18):1291-7. DOI:10.1056/NEJMoa003417
27. Williams R, Creasy R, Cunninhan G, Hawes W, Norris F, Tashiro M. Fetal growth and perinatal viability in California. Obstet Gynecol.1982;59(5):624-32.
28. World Health Organization. Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser. 2003;916:i-viii,1-149.
Av. Bandeirantes, 3900
14049-900 Ribeirão Preto, SP, Brasil
Funded by Fundação de Amparo à Pesquisa do estado de São Paulo (FAPESP - Process nº 00/09508-7), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Apoio ao Ensino, Pesquisa e Assistência (FAEPA) do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
Presented at Pediatric Academic Societies' & Asian Society for Pediatric Research Joint Meeting, 2011, Denver, Colorado and 52nd Annual meeting of the European Society for Paediatric Research, Newcastle, UK, 2011.
The authors declare no conflicts of interest.
a International Physical Activity Questionnaire. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ): Short and Long Forms. Stockholm; 2005 [cited 2006 Mar 3]. Available from: http://www.ipaq.ki.se/scoring.pdf